OrbiMed Capital GP VII LLC, Director, 10% Owner at Enliven Therapeutics, Inc. (ELVN), sold 1,033,300 shares at $22.14 ($22.9M) on 2024-05-16, disclosed to the SEC on 2024-05-20.
Open-market sale of $22.9M ELVN by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.14 | 33,300 | $737K | 3.2% |
| 2 | $22.14 | 1,000,000 | $22.1M | 96.8% |
| Total | $22.14 avg | 1,033,300 | $22.9M | 100% |
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |